| Treatment of advanced squamous cell carcinoma of the lung: a review BA Derman, KF Mileham, PD Bonomi, M Batus, MJ Fidler Translational lung cancer research 4 (5), 524, 2015 | 108 | 2015 |
| International harmonization in performing and reporting minimal residual disease assessment in multiple myeloma trials LJ Costa, BA Derman, S Bal, S Sidana, S Chhabra, R Silbermann, JC Ye, ... Leukemia 35 (1), 18-30, 2021 | 95 | 2021 |
| Results from a multidisciplinary clinic guided by geriatric assessment before stem cell transplantation in older adults BA Derman, K Kordas, J Ridgeway, S Chow, W Dale, SM Lee, E Aguada, ... Blood advances 3 (22), 3488-3498, 2019 | 68 | 2019 |
| Relationships between longitudinal neutrophil to lymphocyte ratios, body weight changes, and overall survival in patients with non-small cell lung cancer BA Derman, JN Macklis, MS Azeem, S Sayidine, S Basu, M Batus, ... BMC cancer 17, 1-6, 2017 | 68 | 2017 |
| Carfilzomib, lenalidomide, and dexamethasone plus transplant in newly diagnosed multiple myeloma JK Jasielec, T Kubicki, N Raje, R Vij, D Reece, J Berdeja, BA Derman, ... Blood, The Journal of the American Society of Hematology 136 (22), 2513-2523, 2020 | 65 | 2020 |
| Geriatric assessment in older alloHCT recipients: association of functional and cognitive impairment with outcomes RL Olin, C Fretham, MC Pasquini, M Arora, VR Bhatt, B Derman, SA Giralt, ... Blood advances 4 (12), 2810-2820, 2020 | 51 | 2020 |
| Measurable residual disease assessed by mass spectrometry in peripheral blood in multiple myeloma in a phase II trial of carfilzomib, lenalidomide, dexamethasone and autologous … BA Derman, AT Stefka, K Jiang, A McIver, T Kubicki, JK Jasielec, ... Blood Cancer Journal 11 (2), 19, 2021 | 45 | 2021 |
| Racial differences in treatment and outcomes in multiple myeloma: a multiple myeloma research foundation analysis BA Derman, J Jasielec, SS Langerman, W Zhang, AJ Jakubowiak, ... Blood cancer journal 10 (8), 80, 2020 | 45 | 2020 |
| Efficacy and toxicity of reduced vs. standard dose pegylated asparaginase in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia BA Derman, M Streck, J Wynne, TN Christ, E Curran, W Stock, ... Leukemia & lymphoma 61 (3), 614-622, 2020 | 33 | 2020 |
| Carfilzomib, lenalidomide, and dexamethasone or lenalidomide alone as maintenance therapy after autologous stem-cell transplantation in patients with multiple myeloma (ATLAS … D Dytfeld, T Wróbel, K Jamroziak, T Kubicki, P Robak, A Walter-Croneck, ... The Lancet Oncology 24 (2), 139-150, 2023 | 32 | 2023 |
| Results from the first phase 1 clinical study of the B-cell maturation antigen (BCMA) Nex T chimeric antigen receptor (CAR) T cell therapy CC-98633/BMS-986354 in patients (pts … LJ Costa, SK Kumar, S Atrash, M Liedtke, G Kaur, BA Derman, ... Blood 140 (Supplement 1), 1360-1362, 2022 | 28 | 2022 |
| Sex differences in outcomes in multiple myeloma BA Derman, SS Langerman, M Maric, A Jakubowiak, W Zhang, BCH Chiu British journal of haematology 192 (3), e66, 2021 | 25 | 2021 |
| Risk factors, diagnosis, management, and outcome of splanchnic vein thrombosis: a retrospective analysis BA Derman, HC Kwaan Seminars in thrombosis and hemostasis 41 (05), 503-513, 2015 | 24 | 2015 |
| Updated phase I study results of PHE885, a T-Charge manufactured BCMA-directed CAR-T cell therapy, for patients (pts) with r/r multiple myeloma (RRMM). AS Sperling, BA Derman, S Nikiforow, SY Im, S Ikegawa, RH Prabhala, ... Journal of Clinical Oncology 41 (16_suppl), 8004-8004, 2023 | 22 | 2023 |
| Elotuzumab and weekly carfilzomib, lenalidomide, and dexamethasone in patients with newly diagnosed multiple myeloma without transplant intent: a phase 2 measurable residual … BA Derman, A Kansagra, J Zonder, AT Stefka, DL Grinblatt, LD Anderson, ... JAMA oncology 8 (9), 1278-1286, 2022 | 22 | 2022 |
| Recommendations for prevention and management of chemotherapy-induced peripheral neuropathy BA Derman, AM Davis JAMA 326 (11), 1058-1059, 2021 | 18 | 2021 |
| Diagnosis and treatment of mixed phenotype (T-myeloid/lymphoid) acute leukemia with novel ETV6-FGFR2 rearrangement T Carll, A Patel, B Derman, E Hyjek, A Lager, P Wanjari, J Segal, ... Blood Advances 4 (19), 4924-4928, 2020 | 14 | 2020 |
| Regulatory T-cell depletion in the setting of autologous stem cell transplantation for multiple myeloma: pilot study BA Derman, Y Zha, TM Zimmerman, R Malloy, A Jakubowiak, MR Bishop, ... Journal for Immunotherapy of Cancer 8 (1), 2020 | 14 | 2020 |
| Antibody and T cell responses to COVID-19 vaccination in patients receiving anticancer therapies SJ Rouhani, J Yu, D Olson, Y Zha, A Pezeshk, A Cabanov, AR Pyzer, ... Journal for immunotherapy of cancer 10 (6), 2022 | 13 | 2022 |
| Recommendations and outcomes from a geriatric assessment guided multidisciplinary clinic prior to autologous stem cell transplant in older patients BA Derman, K Kordas, E Molloy, S Chow, W Dale, AJ Jakubowiak, ... Journal of Geriatric Oncology 12 (4), 585-591, 2021 | 13 | 2021 |
h.kwaanFeinberg School of Medicine在 northwestern.edu 的电子邮件经过验证
